Journals 2026

CAPRIELLO, I., A. DÖMLING
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. ACS Pharmacology & Translational Science. 2026, 9(4), 764-770, ISSN: 2575-9108, PMID: 41988370,  PDF.
DENZLER, A., D. SRIRAMULU, J. PECHA, P. POLISHCHUK
CReM-pharm: de novo 3D pharmacophore-based design with synthetic accessibility awareness. Journal of Cheminformatics. 2026, ISSN: 1758-2946, PMID: 41987310,  PDF.
VAN DER STRAAT, R., R. OERLEMANS, Y. CONG, J. BOXMA, R. BULAI, C. RIO-BERGE, L. KOEKEMOER, T. ZARGANES-TZITZIKAS, M. GUAN, P. MARPLES, F. REGGIORI, M. GROVES, A. DÖMLING
Ugi-Tetrazole-Derived α‑Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV‑2 3CLpro. ACS Medicinal Chemistry Letters. 2026, 17(4), 856-865, ISSN: 1948-5875, PMID: 41982734,  PDF.
VAN DER STRAAT, R., J. KALINOWSKA-TLUSCIK, K. KURPIEWSKA, A. DÖMLING
Systematic Expansion of an Ugi-Based Multicomponent Synthesis of Tetrasubstituted Imidazoles. ACS Omega. 2026, 11(13), 20889-20894, ISSN: 2470-1343, PMID: 41970876,  PDF.
CHEN, S., M. CAL, Q. MONDILE, R. OERLEMANS, M. MUKIM, A. DÖMLING, O. BISHOP, P. MASER, M. GROVES
Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi. ChemMedChem. 2026, 21(6), e202500817, ISSN: 1860-7179, PMID: 41886248,  PDF.
DAS, V., M. HAJDÚCH
Oncology drug repurposing as a blueprint for Alzheimer's therapy. Alzheimer's & dementia. 2026, 12(1), e70231, ISSN: 2352-8737, PMID: 41816361,  PDF.
RAMMAH, M., A. REYES ROMERO, N. HALABI, S. ABUAQUEL, A. GUENNOUN, A. DÖMLING, J. SHAN, L. CHOUCHANE
A small‑molecule HDAC/PDE modulator activates human adipocyte UCP1 and resolves inflammatory signaling. Journal of Translational Medicine. 2026, ISSN: 1479-5876, PMID: 41787480,  PDF.
TAS, H., M. SCHAFER, U. SHUJA-UDDIN, U. BAUDER-WUST, L. KOVACS DOS SANTOS, L. BARNITZKY, F. ODEN, M. PLATZK, T. KONIG, P. RUTHER, E. POOK, K. DVOŘÁKOVÁ BENDOVÁ, Z. NOVÝ, M. PETŘÍK, U. HAGEMANN, M. BENESOVA-SCHAFER
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics. 2026, ISSN: 1543-8384, PMID: 41774810,  PDF.
RANC, V., L. ŽÁRSKÁ
Boron Theranostic Nanoplatform Utilizing a GO@Carborane@Au Hybrid Framework for Targeted Delivery. Pharmaceuticals . 2026, 18(2), 188, ISSN: 1999-4923, PMID: 41754930,  PDF.
EL-MAGHRABY, O., K. SALAMA, M. YOUSSEF, M. MARWA ABDEL-KAREEM
Untargeted GC-MS metabolic profiling of Eurotium chevalieri AUMC 16390 (PX498623) reveals a putative steroidal metabolite with antibacterial and anti-inflammatory potential. BMC Biotechnology. 2026, ISSN: 1472-6750, PMID: 41723428,  PDF.